Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Gains from Investment Securities: 2013-2025

Historic Gains from Investment Securities for Fortress Biotech (FBIO) over the last 8 years, with Jun 2025 value amounting to $540,000.

  • Fortress Biotech's Gains from Investment Securities rose 369.57% to $540,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $540,000, marking a year-over-year decrease of 67.95%. This contributed to the annual value of $9.0 million for FY2024, which is 6641.42% up from last year.
  • Latest data reveals that Fortress Biotech reported Gains from Investment Securities of $540,000 as of Q2 2025, which was down 0.00% from $540,000 recorded in Q1 2025.
  • Fortress Biotech's Gains from Investment Securities' 5-year high stood at $1.7 million during Q3 2022, with a 5-year trough of -$346,000 in Q2 2022.
  • In the last 3 years, Fortress Biotech's Gains from Investment Securities had a median value of $115,000 in 2024 and averaged $341,750.
  • Per our database at Business Quant, Fortress Biotech's Gains from Investment Securities skyrocketed by 983.44% in 2022 and then tumbled by 197.20% in 2023.
  • Quarterly analysis of 5 years shows Fortress Biotech's Gains from Investment Securities stood at $332,000 in 2021, then surged by 349.10% to $1.5 million in 2022, then crashed by 92.29% to $115,000 in 2023, then tumbled by 36.52% to $73,000 in 2024, then surged by 369.57% to $540,000 in 2025.
  • Its last three reported values are $540,000 in Q2 2025, $540,000 for Q1 2025, and $73,000 during Q4 2024.